Results

Total Results: 900 records

Showing results for "author year description".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
    November 01, 2024 - Primary studies: Data were extracted into tables for the following fields: first author, year, study … KQ1 and KQ2 characteristics of included SRs (all low quality) Author Year; # of Studies; Total N; … of the Evidence 8 Author Year; # of Studies; Total N; CKD Stage; Periodontal Condition; … of the Evidence 9 Author Year; Country; Funding Source; CKD Stage Quality Design; Total … No meta- 3.3.2 Results, Key Question 4, Detailed Description of the Evidence 25 Author Year;
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
    January 01, 2024 - Characteristics of Included KQ 1 and KQ 2 RCTs First Author Last Name, Year of Publication Citation … Intervention 2 Description Intervention 3 Description Intervention 4 Description Intervention 5 Description … Characteristics of Included KQ 1 and KQ 2 NRSIs First Author Last Name, Year of Publication Citation … Outcomes of Included KQ 1 NRSIs First Author Last Name, Year of Publication Citation Actual Followup … Outcomes of Included KQ 2 NRSIs First Author Last Name, Year of Publication Citation Actual Followup
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
    March 01, 2018 - primary outcomes 3 Description of secondary outcome Analysis Description of the pre-specified … or the year of study completion. … Description of the Identified Studies Question 2. … Description of the Identified Studies Question 2. … Description of the Identified Studies Question 2.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
    November 01, 2024 - , Outcomes Detail 13 Author, Year; Country; Funding Source; DM Stage; Quality Design; … Statistically significant changes in outcomes in studies mapping to KQ2 Author Year; Country; N; … , Key Points 15 Author Year; Country; N; Intervention vs Control; Study Design; Quality … , Key Points 16 Author Year; Country; N; Intervention vs Control; Study Design; Quality … , Detailed Description 23 Author Year; Quality of SR; Quality of Included Studies; Certainty
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
    July 27, 2023 - Intervention RQs 1-4: Not applicable (description of harms associated with anticoagulant use in the … Description of Included Studies To efficiently describe eligible studies, the full text of each potentially … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, study design, number of study part... … To describe eligible systematic reviews, a single team member will prepare a summary including the author
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
    July 01, 2010 - ...........................................................................................7 Author … Results Description of the Cohort We received data on 1,234,540 individuals meeting the broad criteria … Description of Individuals Using Exenatide by Treatment Period In Table 1 is a description of the patients … Description of individuals with diabetes mellitus stratified by injectable medication use Covariates … Description of individuals with diabetes mellitus stratified by injectable medication use (continued)
  7. effectivehealthcare.ahrq.gov/sites/default/files/mental-illness-disparities_disposition-comments.pdf
    May 26, 2016 - Comment Response Peer Reviewer #1 Findings I also thought that more information was needed on the description … We rearranged the report structure to add a description of the findings to the beginning of the result … We have included a description of and a citation for the DECIDE study in the “Future Areas for Research … Peer Reviewer #2 Background The Background was thorough in its description of the clinical problem … Peer Reviewer #4 Methods “Systematic review” may not be the most appropriate description of this
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
    September 01, 2011 - However, a description of meta-analysis goes beyond this report. … The description of industry funding has been removed. … The description of industry funding has been removed. … (Lovell, Reiff, Jones, et al., 2006) or 8-year (Lovell, Reiff, Ilowite, et al., 2008 follow- up. … However, the description of methotrexate has been expanded.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
    September 01, 2020 - This report is made available to the public under the terms of a licensing agreement between the author … Implementation Strategies No description No description No description No description No description … No description No description No description 28. … Organizational History of Change No description No description No description No description No description … Fidelity No description No description No description No description No description No description
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-disposition-comments.pdf
    October 29, 2021 - high-utilizers-health-care/research Published Online: October 29, 2021 2 Summary of Peer Reviewer Comments and Author … Changes included improving the description of the inclusion/exclusion criteria in methods; more clearly … We expanded our description of the realist review literature rigor assessment to better explain how … high-utilizers-health-care/research Published Online: October 29, 2021 5 Public Comments and Author … stakeholder interpretation of LCA and k-means outputs, and demonstrates significant differences in 1-year
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nursing-staff-shortages-rapid-research-appendix-c.xlsx
    January 01, 2024 - Characteristics and outcomes of included systematic reviews Author, Year Objectives/Aim Population Inclusion … of Participants, n Comparator Intervention Category Interventions Description Patient Safety Outcome … 2016–2017, 16.7% for the year 2017–2018, and 5.7% for the year 2018–2019. … Barriers, facilitators, and resources reported in primary studies Author, Year Study Design Intervention … Author, Year Risk of Bias Judgment: Confounding Risk of Bias Judgment: Selection Risk of Bias Judgment
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
    July 01, 2023 - Timing Original studies published from 2019 onwards, the year of the search done for the MHS III report … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … , year, study design, number of study participants, and main findings relevant to the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, number of studies by study design, and main findings relevant to each of our review questions
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
    January 15, 2013 - Evidence Table Study Description Intervention Inclusion/Exclusion Criteria/ Population Baseline … on a protein-restricted diet and the rest were on BH4. 97.7% of the early diagnosed Study Description … Analysis of lifetime Phe data showed that Phe levels at ages 4, 5, and 6 accounted for Study Description … within therapeutic targets and a decrease in the values above target…, and decreased the Study Description … No studies identified Study Description Intervention Inclusion/Exclusion Criteria/ Population
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - Was there a clear description of the techniques used to identify the events? 5. … Was the description of the population adequate? 2. … Trials of rofecoxib vs NSAIDs Author year Aspirin permitted? … Trials of etoricoxib and lumiracoxib (Safety only) Author Year Patient masked? … Topical NSAIDs trials External Validity Author Year Patient masked?
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
    July 01, 2023 - • No outcome of interest Timing Original studies published from 2011 onwards, the year of the … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … , year, study design, number of study participants, and main findings relevant to the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, number of studies by study design, and main findings relevant to each of our review questions
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
    January 01, 2025 - Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5 First Author Last Name Year of Publication … KQ 3 Outcomes (Accuracy) First Author Last Name Year of Publication Study Design Cancer Type Analyte … KQ 5 Outcomes (Harms) First Author Last Name Year of Publication KQ 5 Harm Outcomes Lennon 2020 Of … Risk of bias of included studies for KQ 4 and KQ 5 First Author Last Name Year of Publication Is it … TACIT for systematic reviews in CQ 1 First Author Last Name Year of publication 1.1 Did any funders
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
    January 01, 2025 - Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5 First Author Last Name Year of Publication … KQ 3 outcomes (accuracy) First Author Last Name Year of Publication Study Design Cancer Type Analyte … KQ 5 outcomes (harms) First Author Last Name Year of Publication KQ 5 Harm Outcomes Lennon 2020 Of … Risk of bias of included studies for KQ 4 and KQ 5 First Author Last Name Year of Publication Is it … TACIT for systematic reviews in CQ 1 First Author Last Name Year of Publication 1.1 Did any funders
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
    May 26, 2017 - The excluded studies appendix is organized by year and then alphabetically. … There is a short but concise description of ASD and the problems associated with the condition. … We did not set specific parameters for small, medium, or large; we acknowledge that our description … TEP Reviewer #5 Results I am not sure from the description why melatonin is not low SOE. … Discussion/Conclu sion Finally, ref. 42 is not correct – it is to an RCT protocol by the same author
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/making-healthcare-safer-IV.pdf
    August 04, 2023 - In the United States, more than 2.8 million antimicrobial-resistant infections occur each year and … Usual practice or other type of PSP • No concurrent or historical comparison group • No clear descriptionDescription of Included Studies To efficiently describe eligible studies, the full text of each potentially … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … To describe eligible systematic reviews, a single team member will prepare a summary including the author
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-term-care-adults_disposition-comments.pdf
    November 07, 2012 - We have revised the description of costs. … We have revised the description of costs. … We have revised the description of costs. … Organizing the table by author name makes the information hard to use. … We have included a description of this.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: